Results 101 to 110 of about 132,140 (136)

Collaboration with community partners to expand naloxone access in the HEALing Communities Study. [PDF]

J Am Pharm Assoc (2003)
Ingram T, Rubi S, Dantzler S, DeFiore-Hyrmer J, Brown JL, Sprunger J, Winhusen TJ, Lyons MS.   +7 more
europepmc   +1 more source

Efficacy of Levocetirizine in Reducing Double-J Stent-Related Symptoms: A Double-Blind Pilot Randomized Controlled Trial. [PDF]

Adv Urol
Elias M, Halaby R, Mina A, Azar Z, Assaf S, El-Khoury G, Ghosh M, Breidy S, Hachem C, Dabal C, Kassis A, El-Khoury R, Saad R.   +12 more
europepmc   +1 more source

Dose-dependent association of naldemedine and magnesium oxide in the management of opioid-induced constipation. [PDF]

Support Care Cancer
Hoshino R, Ishihara M, Watanabe D, Goto S, Nakaya H, Kobayashi R, Suzuki A.   +6 more
europepmc   +1 more source

Practical guidance for navigating buprenorphine discontinuation. [PDF]

Harm Reduct J
Sonoda K, Hilmer AB, Bello JK.
europepmc   +1 more source

Impact of Bystander Naloxone on Emergency Medical Transport Refusal After Opioid Overdose: A Statewide Retrospective Analysis. [PDF]

West J Emerg Med
Carnevale DM, Canning P, Kostyun R, Kamin R.   +3 more
europepmc   +1 more source

Treatment of Opioid-Induced Constipation: Inducing Laxation and Understanding the Risk of Gastrointestinal Perforation. [PDF]

J Clin Gastroenterol
Mehta N, Laitman AP, Brookfield RB, Harris LA.   +3 more
europepmc   +1 more source

Street Pharmacology: The Mechanistic Basis of Clinical Pharmacology Underlying the Microdosing Method of Buprenorphine-Naloxone With a Focus on the Unhoused Population. [PDF]

J Clin Pharmacol
Lehmann DF, Tanner O, Pepple E, Smith ZR, Ruiz-Salvador M.   +4 more
europepmc   +1 more source

Examining Removal of Federal Waiver Restrictions to Prescribing Buprenorphine in Primary Care. [PDF]

J Am Board Fam Med
Simon CB, Hsu C, Prado MG, West II, Chan KCG, LeMaster JW, Hatch MA, Tong ST, Stephens KA.   +8 more
europepmc   +1 more source

Mu or delta opioid receptor antagonists increase the expression of social conditioned place preference in early adolescent mice. [PDF]

Psychopharmacology (Berl)
Harda Z, Klimczak M, Misiołek K, Chrószcz M, Rzeszut A, Szumiec Ł, Kaczmarczyk-Jarosz M, Ryguła R, Ziółkowska B, Rodriguez Parkitna J.   +9 more
europepmc   +1 more source

Comparative Effectiveness of Naltrexone Formulations in Alcohol Use Disorder: An Updated Meta-Analysis. [PDF]

Psychopharmacol Bull
Nunez NA, Ali HM, Hassett L, Singh B.
europepmc   +1 more source